Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma

European Urology

Volumn 64, Issue 5, 2013, Pages 799-810

  Bekema, Hendrika J ^a   Maclennan, Steven ^b   Imamura, Mari ^b   Lam, Thomas B L ^b,c   Stewart, Fiona ^d   Scott, Neil ^b   Maclennan, Graeme ^d   McClinton, Sam ^c   Griffiths, T R Leyshon ^e   Skolarikos, Andreas ^f   Maclennan, Sara J ^b   Sylvester, Richard ^g   Ljungberg, Börje ^h   N'Dow, James ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e LEICESTER GENERAL HOSPITAL   (United Kingdom)

^f SISMANOGLIO HOSPITAL   (Greece)

^g EORTC DATA CENTER   (Belgium)

^h UMEÅ UNIVERSITY   (Sweden)

Author keywords

Adrenalectomy; Adverse events; Locally advanced renal cancer; Lymph node dissection; Lymphadenectomy; Oncologic outcomes; Radical nephrectomy; Systematic review

Indexed keywords

ADRENALECTOMY; ADVANCED CANCER; ADVERSE OUTCOME; CANCER SPECIFIC SURVIVAL; COMPARATIVE STUDY; DISEASE SPECIFIC SURVIVAL; HUMAN; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; META ANALYSIS; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; REVIEW; STATISTICAL SIGNIFICANCE; STUDY DESIGN; SURVIVAL RATE; SYSTEMATIC REVIEW;

ADRENALECTOMY; ADVERSE EVENTS; LOCALLY ADVANCED RENAL CANCER; LYMPH NODE DISSECTION; LYMPHADENECTOMY; ONCOLOGIC OUTCOMES; RADICAL NEPHRECTOMY; SYSTEMATIC REVIEW;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; CARCINOMA, RENAL CELL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84885427126     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.04.033     Document Type: Review

References (52)

1. Chittoria N, Rini BI. Renal cell carcinoma. Cleveland Clinic Center for Continuing Education Web site. http://www.clevelandclinicmeded.com/medicalpubs/ diseasemanagement/nephrology/renal-cell-carcinoma. 2012. Accessed March 2013.
2. V. Ficarra, G. Novara, and M. Iafrate Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome Eur Urol 51 2007 722 731
3. L. Sobin, M. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours ed. 7 2010 Wiley New York, NY
4. R.L. O'Malley, G. Godoy, J.A. Kanofsky, and S.S. Taneja The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review J Urol 181 2009 2009 2017
5. E.L. Robey, and P.F. Schellhammer The adrenal gland and renal cell carcinoma: is ipsilateral adrenalectomy a necessary component of radical nephrectomy? J Urol 135 1986 453 455
6. P. Winter, W.D. Miersch, J. Vogel, and N. Jaeger On the necessity of adrenal extirpation combined with radical nephrectomy J Urol 144 1990 842 843
7. D.S. Sandock, A.D. Seftel, and M.I. Resnick Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage Urology 49 1997 28 31
8. K.H. Tsui, O. Shvarts, and Z. Barbaric Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies J Urol 163 2000 437 441
9. C.J. Weight, S.P. Kim, and C.M. Lohse Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland Eur Urol 60 2011 458 464
10. Ljungberg B, Bensalah K, Bex A, et al. Guidelines on renal cell carcinoma. European Association of Urology Web site. http://www.uroweb.org/gls/ pdf/10-Renal-Cell-Carcinoma-LR.pdf. Accessed March 2013.
11. B.R. Lane, H.Y. Tiong, and S.C. Campbell Management of the adrenal gland during partial nephrectomy J Urol 181 2009 2430 2436
12. J.H. Blom, P.H. Van, and J.M. Marechal Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881 Eur Urol 55 2009 28 34
13. A. Minervini, L. Lilas, and G. Morelli Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 88 2001 169 172
14. R. Paul, J. Mordhorst, R. Busch, H. Leyh, and R. Hartung Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm J Urol 166 2001 59 62
15. J. Reynard, S. Brewster, and S. Biers Oxford handbook of urology ed. 2 2009 Oxford University Press Oxford, UK
16. U.E. Studer, S. Scherz, and J. Scheidegger Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases J Urol 144 1990 243 245
17. C. Terrone, S. Guercio, and S. De Luca The number of lymph nodes examined and staging accuracy in renal cell carcinoma BJU Int 91 2003 37 40
18. U. Capitanio, F. Becker, and M.L. Blute Lymph node dissection in renal cell carcinoma Eur Urol 60 2011 1212 1220
19. B.F. Chapin, S.E. Delacroix Jr., and C.G. Wood The role of lymph node dissection in renal cell carcinoma Int J Clin Oncol 16 2011 186 194
20. P.L. Crispen, R.H. Breau, and C. Allmer Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates Eur Urol 59 2011 18 23
21. S. MacLennan, M. Imamura, and M.C. Lapitan Systematic review of oncological outcomes following surgical management of localised renal cancer Eur Urol 61 2012 972 993
22. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration Web site. http://www.cochrane-handbook.org/. Accessed May 2011.
23. Reeves B, Shea B, Wells G. Classifying non-randomised studies (NRS) and assessing the risk of bias for a systematic review. Workshop at the 18th Cochrane Colloquium; 2010; Keystone, CO.
24. Imamura M, MacLennan S, Lapitan MC, et al. Systematic review of the clinical effectiveness of surgical management for localised renal cell carcinoma: final report. European Association ofUrology Web site. http://www.uroweb.org/gls/refs/LRCC-report-v19-20120216.pdf. October 2011.
25. MacLennan S, Imamura M, Dahm P, et al. Assessing risk of bias in non-randomised studies and incorporating GRADE: initial experience with a new Cochrane "risk of bias" tool under development. Presented at: 19th Cochrane Colloquium; October 18-22, 2011; Madrid, Spain.
26. Palmer D, MacLennan S, Imamura M, et al. Initial experience with a pilot Cochrane tool for assessing risk of bias for non-randomized studies applying a Web-based survey of content experts to derive criteria for imbalance. Presented at: 19th Cochrane Colloquium; October 18-22, 2011; Madrid, Spain.
27. Schunemann H, Brozek J, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendation, version 3.2. The GRADE Working Group. http://www.cc-ims.net/gradepro. Accessed August 2012.
28. Y. Falck-Ytter, H. Schunemann, and G. Guyatt AHRQ series commentary, I: rating the evidence in comparative effectiveness reviews J Clin Epidemiol 63 2010 474 475
29. Rodgers M, Arai L, Britten N, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a comparison of guidance-led narrative synthesis versus meta-analysis. Presented at: 14th Cochrane Colloquium; October 23-26, 2006; Dublin, Ireland. http://www.imbi.uni-freiburg.de/OJS/cca/index.php? journal=cca&page=article&op=view&path[]=2070. Accessed May 2012.
30. Y. Yamashita, A. Ariyoshi, and K. Sakamoto The therapeutic value of lymph node dissection for renal cell carcinoma Nishinihon J Urol 51 1989 777 781
31. A. Herrlinger, K.M. Schrott, G. Schott, and A. Sigel What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146 1991 1224 1227
32. L.D. Sullivan, D.D. Westmore, and M.G. McLoughlin Surgical management of renal cell carcinoma at the Vancouver General Hospital: 20-year review Can J Surg 22 1979 427 431
33. J.P. Siminovitch, J.E. Montie, and R.A. Straffon Lymphadenectomy in renal adenocarcinoma J Urol 127 1982 1090 1091
34. P.C. Peters, and G.L. Brown The role of lymphadenectomy in the management of renal cell carcinoma Urol Clin North Am 7 1980 705 709
35. V. Scattoni, F. Francesca, and L. Broglia Renal tumor and adrenal metastasis: the role of ipsilateral adrenalectomy Acta Urol Ital 7 1993 299 300
36. C. Xu, Z. Niu, J. Lu, and J. Wang Adrenal sparing surgery for renal cell carcinoma Chin Med J 111 1998 877 880
37. J. Delacroix, B.F. Chapin, and J.J. Chen Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol 186 2011 1236 1241
38. U. Capitanio, R. Matloob, and N. Suardi The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma Urologia 79 2012 109 115
39. T. Kondo, and K. Tanabe Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract Int J Urol 19 2012 710 721
40. Guideline management of the clinical stage 1 renal mass. American Urological Association Web site. http://www.auanet.org/content/media/ renalmass09.pdf. Accessed March 2013.
41. S.P. Kim, A.L. Alt, and C.J. Weight Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort J Urol 185 2011 2035 2039
42. W. Kozak, W. Holtl, and K. Pummer Adrenalectomy: still a must in radical renal surgery? Br J Urol 77 1996 27 31
43. M. Kuczyk, T. Munch, and S. Machtens The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience BJU Int 89 2002 517 522
44. S.M. Moudouni, I. En-Nia, and J.J. Patard Real indications for adrenalectomy in renal cell carcinoma Scand J Urol Nephrol 36 2002 273 277
45. S.A. Yap, S.M. Alibhai, R. Abouassaly, N. Timilshina, and A. Finelli Do we continue to unnecessarily perform ipsilateral adrenalectomy at the time of radical nephrectomy? a population based study J Urol 187 2012 398 404
46. J.R. Su, D.J. Zhu, W. Liang, and W.L. Xie Investigation on the indication of ipsilateral adrenalectomy in radical nephrectomy: a meta-analysis Chin Med J 125 2012 3885 3890
47. P. McCulloch, D.G. Altman, and W.B. Campbell No surgical innovation without evaluation: the IDEAL recommendations Lancet 374 2009 1105 1112
48. M. Clarke Standardising outcomes for clinical trials and systematic reviews Trials 8 2007 39
49. P. Tugwell, M. Boers, and P. Brooks OMERACT: an international initiative to improve outcome measurement in rheumatology Trials 8 2007 38
50. P. Williamson, D.G. Altman, J.M. Blazeby, M. Clarke, and E. Gargon The COMET (Core Outcome Measures in Effectiveness Trials) initiative Trials 12 Suppl 1 2012 A70
51. P. Dahm, C.R. Chapple, and B.R. Konety The future of clinical practice guidelines in urology Eur Urol 60 2011 72 74
52. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement PLoS Med 6 2009 e1000097